Singanayagam, Aran
Glanville, Nicholas
Girkin, Jason L. http://orcid.org/0000-0002-0739-1070
Ching, Yee Man
Marcellini, Andrea
Porter, James D.
Toussaint, Marie
Walton, Ross P.
Finney, Lydia J.
Aniscenko, Julia
Zhu, Jie
Trujillo-Torralbo, Maria-Belen
Calderazzo, Maria Adelaide
Grainge, Chris
Loo, Su-Ling
Veerati, Punnam Chander
Pathinayake, Prabuddha S.
Nichol, Kristy S.
Reid, Andrew T.
James, Phillip L.
Solari, Roberto
Wark, Peter A. B. http://orcid.org/0000-0001-5676-6126
Knight, Darryl A.
Moffatt, Miriam F.
Cookson, William O. http://orcid.org/0000-0001-9551-4677
Edwards, Michael R.
Mallia, Patrick
Bartlett, Nathan W.
Johnston, Sebastian L. http://orcid.org/0000-0003-3009-9200
Article History
Received: 11 September 2017
Accepted: 10 May 2018
First Online: 8 June 2018
Competing interests
: S.L.J. has personally received consultancy fees from Myelo Therapeutics GmbH, Concert Pharmaceuticals, Bayer, and Sanofi Pasteura, and Aviragen; he and his institution received consultancy fees from Synairgen, Novarits, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, and Centocor. S.L.J. is an inventor on patents on the use of inhaled interferons for treatment of exacerbations of airway diseases. M.A.C. was employed by Chiesi Pharmaceuticals from January 2015 to November 2017. The remaining authors declare no competing interests.